Gyre Therapeutics Inc (GYRE)

Jun 13, 2025

Gyre Therapeutics, Inc. (GYRE) Raises $23M in Public Stock Offering to Fund Liver Fibrosis Trials - MSN

Jun 13, 2025

Jun 10, 2025

Gyre Therapeutics announces first doing in Phase 1 trial of F230 - TipRanks

Jun 10, 2025

Jun 10, 2025

Gyre Therapeutics (GYRE) Begins Phase 1 Trial for Pulmonary Hypertension Drug | GYRE Stock News - GuruFocus

Jun 10, 2025

Jun 10, 2025

Gyre Therapeutics Announces First Dosing in Phase 1 Trial of F230 for Pulmonary Arterial Hypertension in China - TradingView

Jun 10, 2025

Jun 10, 2025

Novel PAH Drug Enters Clinical Trials in $370M China Market, Targeting Rare Disease with High Mortality - Stock Titan

Jun 10, 2025

Jun 06, 2025

Gyre Therapeutics Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 06, 2025

May 29, 2025

Gyre Therapeutics Closes $23 Million Public Offering - marketscreener.com

May 29, 2025

May 29, 2025

Gyre Therapeutics Raises $23M in Public Offering for MASH Clinical Trials | GYRE Stock News - Stock Titan

May 29, 2025

May 29, 2025

Northern Trust Corp Buys 8,624 Shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World

May 29, 2025

May 29, 2025

Gyre Therapeutics Announces Closing of its Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Globe and Mail

May 29, 2025

May 27, 2025

What's Behind The Big Stock Moves? GYRE, KYTX, TNGX... - Nasdaq

May 27, 2025

May 27, 2025

MAC Copper, ATS, Pony AI And Other Big Stocks Moving Higher On Tuesday - Benzinga

May 27, 2025

May 26, 2025

GNI Group Prices Public Offering at $20 Million to Fund Clinical Trials - marketscreener.com

May 26, 2025

May 25, 2025

Gyre Therapeutics slumps 16%, prices $20M stock offering - MSN

May 25, 2025

May 25, 2025

Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Down – What’s Next? - Defense World

May 25, 2025

May 23, 2025

Gyre Therapeutics announces new stock offering By Investing.com - Investing.com Nigeria

May 23, 2025

May 23, 2025

Gyre Therapeutics (GYRE) Launches $20 Million Public Offering - GuruFocus

May 23, 2025

May 23, 2025

Gyre Therapeutics Announces Stock Offering Agreement - TipRanks

May 23, 2025

May 23, 2025

Gyre Therapeutics announces new stock offering - Investing.com

May 23, 2025

May 23, 2025

GYRE Trading Resumes After Temporary Halt | GYRE Stock News - GuruFocus

May 23, 2025

May 23, 2025

Trading Halted for Catalyst Biosciences (GYRE) Due to Volatility | GYRE Stock News - GuruFocus

May 23, 2025

May 23, 2025

Ross Stores, Deckers Outdoor, Xerox Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga

May 23, 2025

May 23, 2025

Gyre Therapeutics commences underwritten public offering - MSN

May 23, 2025

May 23, 2025

Gyre Therapeutics Prices $20 Million Common Stock Offering - marketscreener.com

May 23, 2025

May 23, 2025

GYRE Announces Pricing Below Previous Closing Price | GYRE Stock News - GuruFocus

May 23, 2025

May 22, 2025

Gyre Therapeutics Raises $20M in Public Offering to Advance MASH Liver Fibrosis Treatment - Stock Titan

May 22, 2025

May 22, 2025

Gyre Therapeutics Announces Pricing Of $20 Million Public Offering Of Common Stock At $9.00 Per Share - marketscreener.com

May 22, 2025

May 22, 2025

Gyre Therapeutics Announces Pricing of $20.0 Million Public Offering of Common Stock - Yahoo Finance

May 22, 2025

May 22, 2025

Gyre Therapeutics Meets Primary Endpoint for Compound to Treat Liver Fibrosis - marketscreener.com

May 22, 2025

May 22, 2025

Gyre Therapeutics (GYRE) Achieves Key Milestone with Hydronidone - GuruFocus

May 22, 2025

May 22, 2025

Gyre Therapeutics (GYRE) Achieves Key Milestone with Hydronidone in Phase 3 Trial | GYRE Stock News - GuruFocus

May 22, 2025

May 22, 2025

Gyre Therapeutics tumbles after stock offering launch - TradingView

May 22, 2025

May 22, 2025

Gyre Therapeutics launches public stock offering By Investing.com - Investing.com Canada

May 22, 2025

May 22, 2025

Gyre Therapeutics Announces Proposed Underwritten Public Offering Of Common Stock - marketscreener.com

May 22, 2025

May 22, 2025

Gyre Therapeutics (GYRE) Launches Public Offering to Fund Clinical Trial and Growth | GYRE Stock News - GuruFocus

May 22, 2025

May 22, 2025

Gyre Therapeutics Announces Positive Phase 3 Trial Results for Hydronidone in Liver Fibrosis Treatment, Paving Way for NDA Submission in 2025 - Nasdaq

May 22, 2025

May 22, 2025

Gyre Therapeutics Seeks Fresh Capital: Public Offering to Accelerate Phase 2 MASH Treatment Trial - Stock Titan

May 22, 2025

May 22, 2025

Breakthrough in Liver Disease: Gyre's Phase 3 Drug Achieves 53% Fibrosis Regression, First-in-Class Potential - Stock Titan

May 22, 2025

May 15, 2025

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Shares Purchased by Barclays PLC - Defense World

May 15, 2025

May 14, 2025

Gyre Therapeutics Reports Q1 2025 Financial Results - MSN

May 14, 2025

May 14, 2025

Wells Fargo & Company MN Has $49,000 Holdings in Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World

May 14, 2025

May 13, 2025

GYRE Makes Bullish Cross Above Critical Moving Average - Nasdaq

May 13, 2025

May 12, 2025

1 Stock to Buy Hand Over Fist as ‘Risk On’ Sentiment Gains Momentum - The Globe and Mail

May 12, 2025

May 11, 2025

Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Down – Here’s Why - Defense World

May 11, 2025

May 09, 2025

Gyre Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times

May 09, 2025

May 09, 2025

Gyre Therapeutics Reports Q1 2025 Revenue of $22.1 Million and Progress in Clinical Development and Commercialization Efforts - Nasdaq

May 09, 2025

May 09, 2025

Earnings Flash (GYRE) Gyre Therapeutics Reports Q1 Revenue $22.1M, vs. FactSet Est of $28.4M - marketscreener.com

May 09, 2025

May 07, 2025

Taking A Look At Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) ROE - simplywall.st

May 07, 2025

May 07, 2025

A Note On Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) ROE and Debt To Equity - Yahoo Finance

May 07, 2025

May 05, 2025

Gyre Therapeutics Inc expected to post earnings of 3 cents a shareEarnings Preview - TradingView

May 05, 2025

May 02, 2025

GYREGyre Therapeutics Inc Latest Stock News & Market Updates - Stock Titan

May 02, 2025

Apr 30, 2025

GNI Group Confirms NDA Timeline for Hydronidone - TipRanks

Apr 30, 2025